Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ravaioli

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|June 18, 2013
Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experienceM Del Gaudio, M Ravaioli, G Ercolani, et al.
Transplantation Proceedings|June 17, 2008
Mars and Prometheus: our clinical experience in acute chronic liver failureS Faenza, O Baraldi, M Bernardi, et al.
Transplantation Proceedings|September 27, 2005
Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantationN De Ruvo, A Cucchetti, A Lauro, et al.
Transplantation Proceedings|August 5, 2008
Fluid management of patients undergoing intestinal and multivisceral transplantationA Siniscalchi, S Spedicato, A Dante, et al.
Transplantation Proceedings|February 23, 2010
Psychological adaptation and quality of life of adult intestinal transplant recipients: University of Bologna experienceL Golfieri, A Lauro, E Tossani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2007
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative periodA Lauro, A Amaduzzi, A Dazzi, et al.
Transplantation Proceedings|June 21, 2007
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantationA Lauro, A Dazzi, G Ercolani, et al.
Transplantation Proceedings|August 5, 2008
Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centersM Ravaioli, M Masetti, A Dazzi, et al.
Transplantation Proceedings|August 19, 2007
Coping strategies in intestinal transplantationL Golfieri, A Lauro, E Tossani, et al.
Transplantation Proceedings|February 23, 2010
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative periodC Zanfi, A Lauro, M Cescon, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|June 18, 2013
Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experienceM Del Gaudio, M Ravaioli, G Ercolani, et al.
Transplantation Proceedings|June 17, 2008
Mars and Prometheus: our clinical experience in acute chronic liver failureS Faenza, O Baraldi, M Bernardi, et al.
Transplantation Proceedings|September 27, 2005
Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantationN De Ruvo, A Cucchetti, A Lauro, et al.
Transplantation Proceedings|August 5, 2008
Fluid management of patients undergoing intestinal and multivisceral transplantationA Siniscalchi, S Spedicato, A Dante, et al.
Transplantation Proceedings|February 23, 2010
Psychological adaptation and quality of life of adult intestinal transplant recipients: University of Bologna experienceL Golfieri, A Lauro, E Tossani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2007
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative periodA Lauro, A Amaduzzi, A Dazzi, et al.
Transplantation Proceedings|June 21, 2007
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantationA Lauro, A Dazzi, G Ercolani, et al.
Transplantation Proceedings|August 5, 2008
Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centersM Ravaioli, M Masetti, A Dazzi, et al.
Transplantation Proceedings|August 19, 2007
Coping strategies in intestinal transplantationL Golfieri, A Lauro, E Tossani, et al.
Transplantation Proceedings|February 23, 2010
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative periodC Zanfi, A Lauro, M Cescon, et al.
Pageof 7